| Literature DB >> 33176827 |
Daniela Buonocore1, Manuela Verri2, Andrea Giolitto2, Enrico Doria2, Michele Ghitti3, Maurizia Dossena2.
Abstract
BACKGROUND: Long-chainEntities:
Keywords: Docosahexaenoic acid; Eicosapentaenoic acid; Inflammation; Long-chain n-3 polyunsaturated fatty acids; Nutraceuticals; Oxidative status; Physical exercise
Mesh:
Substances:
Year: 2020 PMID: 33176827 PMCID: PMC7661186 DOI: 10.1186/s12970-020-00391-4
Source DB: PubMed Journal: J Int Soc Sports Nutr ISSN: 1550-2783 Impact factor: 5.150
Anthropometric data
| Age (years) | Weight (kg) | Height (m) | BMI (kg/m | |
|---|---|---|---|---|
| Mean | 25.56 | 60.06 | 1.74 | 19.87 |
| SD | 6.99 | 7.25 | 0.07 | 1.10 |
| Mean | 22.86 | 57.86 | 1.70 | 19.85 |
| SD | 1.57 | 8.34 | 0.10 | 1.51 |
Anthropometric data for Athlete (n 21) and Sedentary (n 18) subjects
Data are expressed as mean values ± SD
Dietary values for Athletes
| Energy needs | N-3 tot (over 4 days) | LARN n-3 (1%En) | N-6 tot (over 4 days) | LARN n-6 (6%En) | LARN | ||
|---|---|---|---|---|---|---|---|
| 2355 | 1.58 | 2.62 | 9.23 | 15.70 | 6.11 | 6.00 | |
| 505 | 1.02 | 0.56 | 6.93 | 3.37 | 1.89 | 0.00 | |
| 0.001 | |||||||
| 0.002 | |||||||
| 0.827 | |||||||
| △ | 39.69% | ||||||
| △ | 45% | ||||||
Data were obtained from a 4-day food diary, elaborated with the software MetaDieta®. The estimated values of Energy needs (kcal), amount of n-3 (g), n-6 (g) and their ratio n-6/n-3 were reported. The obtained data of n-6, n-3 and their ratio were compared with the value of Italian LARN reference (RI)
Data are expressed as mean values ± SD. Statistical analysis: repeated measures analysis of variance; level of significance: p < 0.05; The value of △ % was obtained by comparing values from the 4-day food diary with LARN values. Abbreviation: En, energy
Dietary values for Sedentary subjects
| Energy needs | N-3 tot (over 4 days) | LARN n-3 | N- 6 tot (over 4 days) | LARN n-6 | RATIO (n-6/n-3) | LARN RATIO | |
|---|---|---|---|---|---|---|---|
| 2183 | 1.32 | 2.43 | 5.26 | 14.56 | 4.50 | 6.00 | |
| 323 | 0.53 | 0.36 | 1.70 | 2.16 | 2.03 | 0.00 | |
| 0.009 | |||||||
| 0.001 | |||||||
| 0.211 | |||||||
| △ | 46.17% | ||||||
| △ | 31.88% | ||||||
Data were obtained from a 4-day food diary, elaborated with the software MetaDieta®. The estimated values of Energy needs (kcal), amount of n-3 (g), n-6 (g) and their ratio n-6/n-3 were reported. The obtained data of n-6, n-3 and their ratio were compared with the value of Italian LARN reference (RI)
Data are expressed as mean values ± SD. Statistical analysis: repeated measures analysis of variance; level of significance: p < 0.05; The value of △ % was obtained by comparing values from the 4-day food diary with LARN values. Abbreviation: En, energy
Principal components
| Comp-1 | Comp-2 | Comp-3 | Comp-4 | Comp-5 | |
|---|---|---|---|---|---|
| − 0.25 | 0.31* | − 0.04 | 0.02 | 0.51* | |
| − 0.19 | 0.43* | − 0.25 | 0.12 | 0.04 | |
| − 0.42 | − 0.28 | 0.13 | 0.17 | 0.17 | |
| 0.3 | −0.21 | − 0.05 | 0.12 | 0.46* | |
| −0.22 | 0.3 | −0.38 | 0.04 | 0.36* | |
| 0.1 | − 0.46* | −0.19 | 0.32 | 0.15 | |
| 0.17 | −0.11 | − 0.63 | − 0.12 | − 0.12 | |
| 0.2 | −0.02 | − 0.39 | 0.56 | − 0.16 | |
| −0.01 | − 0.13 | − 0.3 | −0.65 | − 0.08 | |
| −0.46 | − 0.16 | 0.03 | 0.21 | −0.29 | |
| −0.44 | − 0.03 | − 0.18 | 0.07 | − 0.33* | |
| 0.19 | 0.4* | −0.04 | 0.12 | −0.31* | |
| 0.27 | 0.28 | 0.25 | 0.18 | −0.1 |
Principal components (PC, all with eigenvalue > 1), accounting for 60% of total variance, and their scores. The values indicate how the biological parameters affect each component. The symbol (*) indicates the relevant effect on the component
Fig. 1PCA graph. Components graph showing the two selected components (Comp 2 and Comp 5) and parameters
Fig. 2Multivariate Analysis of Variance. Difference in direction of physiological change of Athletes and Sedentary subjects as the angle between their vectors of physiological change considering Components (Comp) 2 and 5
Lipid profile
| T0 | SD | T1 | SD | △ % | ||||
|---|---|---|---|---|---|---|---|---|
| 82 | 34 | 64 | 22 | 21.95 | ||||
| 67 | 15 | 65 | 17 | 2.98 | ||||
| 18.29 | ||||||||
| 1.54 | ||||||||
| 175 | 26 | 171 | 35 | 2.28 | ||||
| 180 | 18 | 184 | 21 | 2.17 | ||||
| 2.78 | ||||||||
| 7.06 | ||||||||
| 50 | 9 | 50 | 11 | 0.00 | ||||
| 54 | 8 | 55 | 9 | 1.82 | ||||
| 8.09 | ||||||||
| 9.10 |
Data are expressed as mean values ± SD comparing two groups and two periods. Statistical analysis: repeated measures analysis of variance; level of significance: p < 0.05;△ % for the difference between mean values, T1vs T0 intra-group, Sedentary (SED) vs Athlete (ATHL) groups for T0 and T1
Muscle workload
| T0 | SD | T1 | SD | △ % | ||||
|---|---|---|---|---|---|---|---|---|
| 0.730 | 0.068 | 0.850 | 0.077 | 14.12 | ||||
| 0.840 | 0.131 | 0.790 | 0.098 | 5.95 | ||||
| 13.09 | ||||||||
| 7.06 | ||||||||
| 187 | 124 | 198 | 115 | 5.56 | ||||
| 56 | 21 | 73 | 39 | 23.29 | ||||
| 70.05 | ||||||||
| 63.13 | ||||||||
| 179 | 38 | 175 | 33 | 2.23 | ||||
| 152 | 50 | 139 | 30 | 8.55 | ||||
| 15.08 | ||||||||
| 20.57 |
Data are expressed as mean values ± SD comparing two groups and two periods. Statistical analysis: repeated measures analysis of variance; level of significance: p < 0.05;△ % for the difference between mean values, T1vs T0 intra-group, Sedentary (SED) vs Athlete (ATHL) groups for T0 and T1
Analysis of Correlation
| MDA | DPPH | T | C | T/C | T | C | T/C | TNFα | Creat | Cholest | Cholest | Trigly | CPK | LDH | HGH | IGF-1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MDAurn | 1.00 | 0.32 | −0.12 | 0.75 | −0.44 | −0.06 | 0.56 | −0.04 | −0.12 | −0.37 | 0.48 | −0.26 | 0.82 | −0.01 | 0.28 | 0.12 | −0.39 |
| DPPHslv | 0.32 | 1.00 | 0.04 | −0.02 | 0.02 | 0.09 | −0.26 | 0.29 | 0.13 | −0.14 | −0.37 | −0.23 | 0.42 | 0.38 | 0.57 | 0.04 | −0.28 |
| T_slv | −0.12 | 0.04 | 1.00 | −0.20 | 0.67 | 0.91 | −0.04 | 0.73 | −0.40 | 0.48 | −0.04 | 0.02 | −0.18 | 0.59 | 0.56 | −0.80 | −0.19 |
| C_slv | 0.75 | −0.02 | −0.20 | 1.00 | −0.77 | − 0.26 | 0.90 | − 0.48 | −0.19 | − 0.48 | 0.51 | − 0.07 | 0.45 | − 0.53 | −0.26 | 0.13 | 0.08 |
| T/C slv | −0.44 | 0.02 | 0.67 | −0.77 | 1.00 | 0.72 | −0.63 | 0.81 | −0.17 | 0.52 | −0.30 | −0.08 | − 0.30 | 0.85 | 0.58 | −0.42 | − 0.30 |
| T_bld | −0.06 | 0.09 | 0.91* | −0.26 | 0.72 | 1.00 | −0.16 | 0.88 | −0.47 | 0.43 | 0.04 | −0.11 | −0.10 | 0.74 | 0.71 | −0.76 | −0.49 |
| C_bld | 0.56 | −0.26 | −0.04 | 0.90 | −0.63 | − 0.16 | 1.00 | − 0.51 | −0.05 | − 0.13 | 0.71 | 0.17 | 0.17 | −0.56 | −0.42 | 0.00 | 0.25 |
| T/C bld | −0.04 | 0.29 | 0.73 | −0.48 | 0.81 | 0.88 | −0.51 | 1.00 | −0.40 | 0.28 | −0.22 | −0.28 | 0.12 | 0.91 | 0.91 | −0.56 | −0.67 |
| TNFαbld | −0.12 | 0.13 | −0.40 | −0.19 | − 0.17 | −0.47 | − 0.05 | −0.40 | 1.00 | 0.37 | 0.09 | 0.14 | 0.03 | −0.29 | −0.36 | 0.30 | 0.18 |
| Creat | −0.37 | −0.14 | 0.48 | −0.48 | 0.52 | 0.43 | −0.13 | 0.28 | 0.37 | 1.00 | 0.27 | 0.48 | −0.51 | 0.27 | 0.06 | −0.58 | 0.07 |
Cholest TOT | 0.48 | −0.37 | −0.04 | 0.51 | −0.30 | 0.04 | 0.71 | −0.22 | 0.09 | 0.27 | 1.00 | 0.39 | 0.10 | −0.27 | −0.21 | − 0.04 | −0.05 |
Cholest HDL | −0.26 | −0.23 | 0.02 | −0.07 | − 0.08 | −0.11 | 0.17 | −0.28 | 0.14 | 0.48 | 0.39 | 1.00 | −0.57 | −0.33 | − 0.36 | −0.01 | 0.66 |
| Trigly | 0.82 | 0.42 | −0.18 | 0.45 | −0.30 | −0.10 | 0.17 | 0.12 | 0.03 | −0.51 | 0.10 | −0.57 | 1.00 | 0.09 | 0.43 | 0.23 | −0.59 |
| CPK | −0.01 | 0.38 | 0.59 | −0.53 | 0.85 | 0.74 | −0.56 | 0.91 | −0.29 | 0.27 | −0.27 | −0.33 | 0.09 | 1.00 | 0.86 | −0.38 | −0.60 |
| LDH | 0.28 | 0.57 | 0.56 | −0.26 | 0.58 | 0.71 | −0.42 | 0.91 | −0.36 | 0.06 | −0.21 | −0.36 | 0.43 | 0.86 | 1.00 | −0.39 | −0.73 |
| HGH | 0.12 | 0.04 | −0.80 | 0.13 | −0.42 | −0.76 | 0.00 | −0.56 | 0.30 | −0.58 | − 0.04 | −0.01 | 0.23 | −0.38 | − 0.39 | 1.00 | 0.26 |
| IGF-1 | −0.39 | −0.28 | − 0.19 | 0.08 | − 0.30 | −0.49 | 0.25 | −0.67 | 0.18 | 0.07 | −0.05 | 0.66 | −0.59 | −0.60 | − 0.73 | 0.26 | 1.00 |
The high values (R > 0.5) indicate a significant correlation between the analyzed parameters. Abbreviations: bld blood; C Cortisol; Cholest Cholesterol; Creat Creatinine; slv saliva; T Testosterone; T/C RATIO T/C; Trigly Triglyceride; urn urine
Muscle Workload
| T0 | SD | T1 | SD | △ % | |||
|---|---|---|---|---|---|---|---|
| 2.9 | 4.5 | 2.6 | 3.6 | 10.34 | |||
| 4.5 | 5.8 | 5.6 | 4.4 | 19.64 | |||
| 35.56 | |||||||
| 53.57 | |||||||
| 290 | 142 | 306 | 115 | 5.23 | |||
| 271 | 78 | 274 | 81 | 1.09 | |||
| 6.55 | |||||||
| 10.46 |
Data are expressed as mean values ± SD comparing two groups and two periods. Statistical analysis: repeated measures analysis of variance; level of significance: p < 0.05;△ % for the difference between mean values, T1vs T0 intra-group, Sedentary (SED) vs Athlete (ATHL) groups for T0 and T1
Oxidative status: MDA, PCc, 8-OHdG
| T0 | SD | T1 | SD | △ % | ||||
|---|---|---|---|---|---|---|---|---|
| 0.030 | 0.017 | 0.019 | 0.011 | 36.67 | ||||
| 0.016 | 0.02 | 0.017 | 0.011 | 5.88 | ||||
| 46.67 | ||||||||
| 10.53 | ||||||||
| 0.026 | 0.015 | 0.002 | 0.002 | 90.59 | ||||
| 0.003 | 0.002 | 0.001 | 0.001 | 58.82 | ||||
| 86.67 | ||||||||
| 41.67 | ||||||||
| 0.053 | 0.017 | 0.016 | 0.003 | 69.19 | ||||
| 0.018 | 0.002 | 0.015 | 0.002 | 18.03 | ||||
| 65.41 | ||||||||
| 7.98 | ||||||||
| 3.83 | 2.85 | 3.73 | 2.32 | 2.71 | ||||
| 3.50 | 2.12 | 5.31 | 1.61 | 34.01 | ||||
| 8.61 | ||||||||
| 29.75 | ||||||||
| 27.87 | 22.50 | 56.47 | 45.60 | 50.65 | ||||
| 73.77 | 75.00 | 67.32 | 63.90 | 8.74 | ||||
| 62.36 | ||||||||
| 16.12 |
Data are expressed as mean values ± SD comparing two groups and two periods. Statistical analysis: repeated measures analysis of variance; level of significance: p < 0.05;△ % for the difference between mean values, T1vs T0 intra-group, Sedentary (SED) vs Athlete (ATHL) groups for T0 and T1
Fig. 3MDA in urine for Athletes and Sedentary subjects in different periods: before (T0) and after (T1) supplementation. Interactions between factors are cogent and significant (L ratio = 6.095124; p value = 0.0136)
Antioxidant parameters: GPx, SOD, CAT, DPPH
| T0 | SD | T1 | SD | △ % | ||||
|---|---|---|---|---|---|---|---|---|
| 9.78 | 2.00 | 13.70 | 3.39 | 28.61 | ||||
| 6.55 | 2.97 | 17.99 | 4.55 | 63.61 | ||||
| 33.08 | ||||||||
| 23.83 | ||||||||
| 722 | 180 | 761 | 129 | 5.05 | ||||
| 598 | 176 | 692 | 65 | 13.68 | ||||
| 17.26 | ||||||||
| 8.95 | ||||||||
| 0.007 | 0.002 | 0.010 | 0.006 | 38.68 | ||||
| 0.007 | 0.002 | 0.028 | 0.008 | 76.49 | ||||
| 2.98 | ||||||||
| 62.81 | ||||||||
| 0.589 | 0.102 | 0.242 | 0.173 | 58.91 | ||||
| 0.457 | 0.047 | 0.373 | 0.067 | 18.38 | ||||
| 22.41 | ||||||||
| 35.12 |
Data are expressed as mean values ± SD comparing two groups and two periods. Statistical analysis: repeated measures analysis of variance; level of significance: p < 0.05;△ % for the difference between mean values, T1vs T0 intra-group, Sedentary (SED) vs Athlete (ATHL) groups for T0 and T1
Fig. 4DPPH in saliva for Athletes and Sedentary subjects in different periods: before (T0) and after (T1) supplementation. Interactions between factors are cogent and significant (L ratio = 15.37332; p value = 1e-04)
Exercise-induced stress levels: Testosterone and Cortisol
| T0 | SD | T1 | SD | △ % | ||||
|---|---|---|---|---|---|---|---|---|
| 4.8 | 3.21 | 4.67 | 2.84 | 1.67 | ||||
| 2.53 | 3.59 | 2.19 | 2.72 | 13.44 | ||||
| 47.29 | ||||||||
| 53.10 | ||||||||
| 151 | 38 | 139 | 49 | 7.88 | ||||
| 108 | 57 | 113 | 41 | 4.17 | ||||
| 28.56 | ||||||||
| 19.07 | ||||||||
| 160 | 53 | 169 | 25 | 5.83 | ||||
| 176 | 35 | 216 | 44 | 18.43 | ||||
| 9.37 | ||||||||
| 21.50 | ||||||||
| 11.11 | 5.12 | 8.54 | 1.06 | 23.13 | ||||
| 7.57 | 3.43 | 12.65 | 3.53 | 40.16 | ||||
| 31.86 | ||||||||
| 32.49 |
Data are expressed as mean values ± SD comparing two groups and two periods. Statistical analysis: repeated measures analysis of variance; level of significance: p < 0.05;△ % for the difference between mean values, T1vs T0 intra-group, Sedentary (SED) vs Athlete (ATHL) groups for T0 and T1
Fig. 5Linear correlation between Testosterone measured in the blood and in saliva. Testosterone: Pearson correlation coefficient (R = 0.91) indicates a high correlation. Pearson correlation test is significant (t = 6.16, df = 8, P-value < 0.001)
Fig. 6Linear correlation between Cortisol measured in the blood and in saliva. Cortisol: Pearson correlation coefficient (R = 0.90) indicates a high correlation. Pearson correlation test is significant (t = 5.83, df = 8, P-value < 0.001)
Fig. 7T/C ratio in plasma blood (A) and saliva (B) for Athletes and Sedentary subjects in different periods: before (T0) and after (T1) supplementation. Data are expressed as mean ± SD
Inflammatory marker: TNF-α
| T0 | SD | T1 | SD | △ % | ||||
|---|---|---|---|---|---|---|---|---|
| 54.57 | 64.80 | 0.05 | 18.80 | 99.91 | ||||
| 18.18 | 0.20 | 0.00 | 0.00 | 100.00 | ||||
| 66.68 | ||||||||
| 100.00 |
Data are expressed as mean values ± SD comparing two groups and two periods. Statistical analysis: repeated measures analysis of variance; level of significance: p < 0.05;△ % for the difference between mean values, T1vs T0 intra-group, Sedentary (SED) vs Athlete (ATHL) groups for T0 and T1
Fig. 8TNF-α in plasma blood for Athletes and Sedentary subjects in different periods: before (T0) and after (T1) supplementation. Interactions between factors are cogent and significant (model MCMCglmm 106 iterations with a burn-in of 10,000 iterations and a thinning interval of 100)